Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
UBS
Boehringer Ingelheim
Chubb
Covington
Julphar
Moodys
Cipla

Generated: April 26, 2018

DrugPatentWatch Database Preview

BLEPHAMIDE Drug Profile

« Back to Dashboard

Which patents cover Blephamide, and when can generic versions of Blephamide launch?

Blephamide is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in BLEPHAMIDE is prednisolone acetate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Drug patent expirations by year for BLEPHAMIDE
Pharmacology for BLEPHAMIDE

US Patents and Regulatory Information for BLEPHAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan BLEPHAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 012813-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan BLEPHAMIDE S.O.P. prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087748-001 Dec 3, 1986 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Farmers Insurance
Teva
Federal Trade Commission
Mallinckrodt
McKesson
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.